These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

399 related items for PubMed ID: 18164013

  • 1. High HDL cholesterol does not protect against coronary artery disease when associated with combined cholesteryl ester transfer protein and hepatic lipase gene variants.
    van Acker BA, Botma GJ, Zwinderman AH, Kuivenhoven JA, Dallinga-Thie GM, Sijbrands EJ, Boer JM, Seidell JC, Jukema JW, Kastelein JJ, Jansen H, Verhoeven AJ, REGRESS Study Group.
    Atherosclerosis; 2008 Sep; 200(1):161-7. PubMed ID: 18164013
    [Abstract] [Full Text] [Related]

  • 2. CETP (cholesteryl ester transfer protein) promoter -1337 C>T polymorphism protects against coronary atherosclerosis in Japanese patients with heterozygous familial hypercholesterolaemia.
    Takata M, Inazu A, Katsuda S, Miwa K, Kawashiri MA, Nohara A, Higashikata T, Kobayashi J, Mabuchi H, Yamagishi M.
    Clin Sci (Lond); 2006 Nov; 111(5):325-31. PubMed ID: 16822236
    [Abstract] [Full Text] [Related]

  • 3. Combined hepatic lipase -514C/T and cholesteryl ester transfer protein I405V polymorphisms are associated with the risk of coronary artery disease.
    Ghatrehsamani K, Darabi M, Rahbani M, Hashemzadeh Chaleshtory M, Farrokhi E, Noori M.
    Genet Test Mol Biomarkers; 2009 Dec; 13(6):809-15. PubMed ID: 19810818
    [Abstract] [Full Text] [Related]

  • 4. Association of cholesteryl ester transfer protein -629C > A polymorphism with high-density lipoprotein cholesterol levels in coronary artery disease patients.
    Tanrikulu S, Ademoglu E, Gurdol F, Mutlu-Turkoglu U, Bilge AK, Nisanci Y.
    Cell Biochem Funct; 2009 Oct; 27(7):452-7. PubMed ID: 19784962
    [Abstract] [Full Text] [Related]

  • 5. The cholesteryl ester transfer protein Taq1B gene polymorphism predicts clinical benefit of statin therapy in patients with significant coronary artery disease.
    Carlquist JF, Muhlestein JB, Horne BD, Hart NI, Bair TL, Molhuizen HO, Anderson JL.
    Am Heart J; 2003 Dec; 146(6):1007-14. PubMed ID: 14660992
    [Abstract] [Full Text] [Related]

  • 6. TaqIB and severity of coronary artery disease in the Turkish population: a pilot study.
    Kaman D, İlhan N, İlhan N, Akbulut M.
    Bosn J Basic Med Sci; 2015 Feb 01; 15(1):9-13. PubMed ID: 25725138
    [Abstract] [Full Text] [Related]

  • 7. Association between CETP Taq1B and LIPC -514C/T polymorphisms with the serum lipid levels in a group of Tehran's population: a cross sectional study.
    Kashani Farid MA, Azizi F, Hedayati M, Daneshpour MS, Shamshiri AR, Siassi F.
    Lipids Health Dis; 2010 Sep 07; 9():96. PubMed ID: 20822508
    [Abstract] [Full Text] [Related]

  • 8. Epistatic effect of cholesteryl ester transfer protein and hepatic lipase on serum high-density lipoprotein cholesterol levels.
    Isaacs A, Aulchenko YS, Hofman A, Sijbrands EJ, Sayed-Tabatabaei FA, Klungel OH, Maitland-van der Zee AH, Stricker BH, Oostra BA, Witteman JC, van Duijn CM.
    J Clin Endocrinol Metab; 2007 Jul 07; 92(7):2680-7. PubMed ID: 17440012
    [Abstract] [Full Text] [Related]

  • 9. Candidate gene susceptibility variants predict intermediate end points but not angiographic coronary artery disease.
    Whiting BM, Anderson JL, Muhlestein JB, Horne BD, Bair TL, Pearson RR, Carlquist JF, Intermountain Heart Collaborative Study Group.
    Am Heart J; 2005 Aug 07; 150(2):243-50. PubMed ID: 16086925
    [Abstract] [Full Text] [Related]

  • 10. Hepatic lipase mutation may reduce vascular disease prevalence in hemodialysis patients with high CETP levels.
    Kimura H, Miyazaki R, Imura T, Masunaga S, Suzuki S, Gejyo F, Yoshida H.
    Kidney Int; 2003 Nov 07; 64(5):1829-37. PubMed ID: 14531818
    [Abstract] [Full Text] [Related]

  • 11. [Genetic variation of the cholesterol ester transfer protein gene and the prevalence of coronary artery disease. The AtheroGene case control study].
    Blankenberg S, Tiret L, Bickel C, Schlitt A, Jungmair W, Genth-Zotz S, Lubos E, Espinola-Klein C, Rupprecht HJ.
    Z Kardiol; 2004 Nov 07; 93 Suppl 4():IV16-23. PubMed ID: 15085362
    [Abstract] [Full Text] [Related]

  • 12. Cholesteryl ester transfer protein and hepatic lipase gene polymorphisms: effects on hepatic mRNA levels, plasma lipids and carotid atherosclerosis.
    Soyal SM, Sandhofer A, Hahne P, Oberkofler H, Felder T, Iglseder B, Miller K, Krempler F, Patsch JR, Paulweber B, Patsch W.
    Atherosclerosis; 2011 Jun 07; 216(2):374-80. PubMed ID: 21371711
    [Abstract] [Full Text] [Related]

  • 13. Effects of cholesterol ester transfer protein Taq1B gene polymorphism on serum lipoprotein levels in Turkish coronary artery disease patients.
    Yilmaz H, Isbir T, Agachan B, Karaali ZE.
    Cell Biochem Funct; 2005 Jun 07; 23(1):23-8. PubMed ID: 15386541
    [Abstract] [Full Text] [Related]

  • 14. Four polymorphisms of cholesteryl ester transfer protein gene and coronary stenosis in a Tunisian population.
    Rejeb J, Omezzine A, Boumaiza I, Rebhi L, Rejeb NB, Nabli N, Abdelaziz AB, Boughzala E, Bouslama A.
    J Cardiovasc Med (Hagerstown); 2012 Sep 07; 13(9):546-53. PubMed ID: 22854712
    [Abstract] [Full Text] [Related]

  • 15. Gender specific effect of CETP rs708272 polymorphism on lipid and atherogenic index of plasma levels but not on the risk of coronary artery disease: A case-control study.
    Cai G, Shi G, Huang Z.
    Medicine (Baltimore); 2018 Dec 07; 97(49):e13514. PubMed ID: 30544452
    [Abstract] [Full Text] [Related]

  • 16. Smaller low-density lipoprotein size as a possible risk factor for the prevalence of coronary artery diseases in haemodialysis patients: associations of cholesteryl ester transfer protein and the hepatic lipase gene polymorphism with low-density lipoprotein size.
    Kimura H, Miyazaki R, Imura T, Masunaga S, Shimada A, Mikami D, Kasuno K, Takahashi N, Hirano T, Yoshida H.
    Nephrology (Carlton); 2011 Aug 07; 16(6):558-66. PubMed ID: 21352420
    [Abstract] [Full Text] [Related]

  • 17. Genetic variation in cholesterol ester transfer protein, serum CETP activity, and coronary artery disease risk in Asian Indian diabetic cohort.
    Schierer A, Been LF, Ralhan S, Wander GS, Aston CE, Sanghera DK.
    Pharmacogenet Genomics; 2012 Feb 07; 22(2):95-104. PubMed ID: 22143414
    [Abstract] [Full Text] [Related]

  • 18. The association of cholesteryl ester transfer protein polymorphism with high-density lipoprotein cholesterol and coronary artery disease in Koreans.
    Park KW, Choi JH, Kim HK, Oh S, Chae IH, Kim HS, Oh BH, Lee MM, Park YB, Choi YS.
    Clin Genet; 2003 Jan 07; 63(1):31-8. PubMed ID: 12519369
    [Abstract] [Full Text] [Related]

  • 19. Cholesteryl ester transfer protein B1B1 genotype as a predictor of coronary artery disease in Taiwanese with type 2 diabetes mellitus.
    Hsieh MC, Tien KJ, Chang SJ, Lo CS, Hsin SC, Hsiao JY, Hsu SC, Liang HT, Chen HC, Shin SJ, Lin SR.
    Metabolism; 2007 Jun 07; 56(6):745-50. PubMed ID: 17512305
    [Abstract] [Full Text] [Related]

  • 20. Common variation in the CETP gene and the implications for cardiovascular disease and its treatment: an updated analysis.
    Dullaart RP, Sluiter WJ.
    Pharmacogenomics; 2008 Jun 07; 9(6):747-63. PubMed ID: 18518852
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.